201. Lin28B is an oncofetal circulating cancer stem cell-like marker associated with recurrence of hepatocellular carcinoma.
- Author
-
Cheng SW, Tsai HW, Lin YJ, Cheng PN, Chang YC, Yen CJ, Huang HP, Chuang YP, Chang TT, Lee CT, Chao A, Chou CY, Chan SH, Chow NH, and Ho CL
- Subjects
- Adult, Aged, Biomarkers, Tumor metabolism, Carcinoma, Hepatocellular mortality, Carcinoma, Hepatocellular pathology, Carcinoma, Hepatocellular surgery, Female, Hep G2 Cells, Hepatectomy, Homeodomain Proteins genetics, Homeodomain Proteins metabolism, Humans, Liver Neoplasms mortality, Liver Neoplasms pathology, Liver Neoplasms surgery, Male, Middle Aged, Nanog Homeobox Protein, Neoplasm Recurrence, Local mortality, Neoplasm Recurrence, Local pathology, Neoplasm Recurrence, Local surgery, Neoplasm Staging, Neoplastic Cells, Circulating metabolism, Neoplastic Cells, Circulating pathology, Neoplastic Stem Cells pathology, Octamer Transcription Factor-3 genetics, Octamer Transcription Factor-3 metabolism, RNA, Messenger genetics, RNA, Messenger metabolism, RNA-Binding Proteins metabolism, SOXB1 Transcription Factors genetics, SOXB1 Transcription Factors metabolism, Survival Analysis, Biomarkers, Tumor genetics, Carcinoma, Hepatocellular genetics, Gene Expression Regulation, Neoplastic, Liver Neoplasms genetics, Neoplasm Recurrence, Local genetics, Neoplastic Stem Cells metabolism, RNA-Binding Proteins genetics
- Abstract
By using an expressed sequence tag bioinformatic algorithm, we identified that Lin28 homolog B (Lin28B) may have an oncofetal expression pattern which may facilitate detecting cancer cells in adults. It is also reported to be a potential marker for cancer stem cells. Therefore, we sought to verify oncofetal-stemness characters of Lin28B and test its potential as a circulating cancer stem cell-like marker in adult HCC patients. Lin28B mRNA was examined in a panel of fetal tissue, adult tissue and tumors. Lin28B was over-expressed or knocked down in HepG2 cells to evaluate its potential as a stem cell-like marker. RT-qPCR for Lin28B was performed in the peripheral blood mononuclear cells from patients with HCC receiving surgery (n=96) and non-HCC controls (n=60) and analyzed its clinical significance. Lin28B showed an oncofetal expression pattern. Its overexpression could upregulate stemness markers (OCT4, Nanog and SOX2) and enhance tumorsphere formation in vitro. Lin28B knockdown had opposite effects. Circulating Lin28B was detected in peripheral blood mononuclear cells in 3 cases (5%) of non-HCC controls and 32 cases (33.3%) of HCC patients. In HCC patients, circulating Lin28B was associated with high tumor grade (P=0.046), large size (P=0.005), high AJCC stage (P=0.044) and BCLC stage (P=0.017). Circulating Lin28B was significantly associated with decreased recurrence-free survival (P<0.001). Circulating Lin28B separated early stage HCC into 2 recurrence-free survival curves (P=0.003). In multivariate analysis, circulating Lin28B was an independent variable associated with early recurrence (P=0.045) and recurrence in early stage HCC (P=0.006). In conclusion, the oncofetal gene Lin28B is a potential oncofetal cancer-stem-cell-like circulating tumor cell marker that correlates with HCC recurrence after hepatectomy. Circulating Lin28B could refine early AJCC stages. Our finding supports the possible use of a TNMC (C for circulating tumor cells) staging system in HCC.
- Published
- 2013
- Full Text
- View/download PDF